DZ2327A1 - Nouvelle composition hormonale et son utilisation. - Google Patents

Nouvelle composition hormonale et son utilisation.

Info

Publication number
DZ2327A1
DZ2327A1 DZ970177A DZ970177A DZ2327A1 DZ 2327 A1 DZ2327 A1 DZ 2327A1 DZ 970177 A DZ970177 A DZ 970177A DZ 970177 A DZ970177 A DZ 970177A DZ 2327 A1 DZ2327 A1 DZ 2327A1
Authority
DZ
Algeria
Prior art keywords
hormonal composition
new hormonal
new
composition
hormonal
Prior art date
Application number
DZ970177A
Other languages
English (en)
French (fr)
Inventor
Michel Lanquetin
Jacques Paris
Jean-Louis Thomas
Original Assignee
Theramex
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9496456&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DZ2327(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Theramex filed Critical Theramex
Application granted granted Critical
Publication of DZ2327A1 publication Critical patent/DZ2327A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26—Androgens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/811—Drug, bio-affecting and body treating compositions involving sex selection or contraception

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
DZ970177A 1996-10-08 1997-10-08 Nouvelle composition hormonale et son utilisation. DZ2327A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9612239A FR2754179B1 (fr) 1996-10-08 1996-10-08 Nouvelle composition hormononale et son utilisation

Publications (1)

Publication Number Publication Date
DZ2327A1 true DZ2327A1 (fr) 2002-12-28

Family

ID=9496456

Family Applications (1)

Application Number Title Priority Date Filing Date
DZ970177A DZ2327A1 (fr) 1996-10-08 1997-10-08 Nouvelle composition hormonale et son utilisation.

Country Status (38)

Country Link
US (4) US6831073B1 (cs)
EP (2) EP1334725B1 (cs)
JP (1) JP4883542B2 (cs)
KR (2) KR20000048981A (cs)
CN (3) CN1239893A (cs)
AP (1) AP1171A (cs)
AR (2) AR009113A1 (cs)
AT (2) ATE238057T1 (cs)
AU (1) AU745571B2 (cs)
BR (1) BR9712274A (cs)
CA (1) CA2268358C (cs)
CL (1) CL2011000017A1 (cs)
CZ (1) CZ298402B6 (cs)
DE (3) DE69721314T2 (cs)
DK (2) DK1334725T3 (cs)
DZ (1) DZ2327A1 (cs)
ES (2) ES2198006T3 (cs)
FR (2) FR2754179B1 (cs)
HK (1) HK1210708A1 (cs)
HU (2) HU227450B1 (cs)
ID (1) ID21569A (cs)
IL (1) IL129194A (cs)
LU (1) LU91932I2 (cs)
MA (1) MA24370A1 (cs)
MY (1) MY128482A (cs)
NO (3) NO324357B1 (cs)
NZ (1) NZ334876A (cs)
OA (1) OA11033A (cs)
PL (1) PL192979B1 (cs)
PT (2) PT956022E (cs)
RU (1) RU2274450C2 (cs)
SK (2) SK285455B6 (cs)
TN (1) TNSN97164A1 (cs)
TR (1) TR199900764T2 (cs)
TW (1) TW491704B (cs)
WO (1) WO1998015279A1 (cs)
YU (1) YU18099A (cs)
ZA (1) ZA979011B (cs)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4344462C2 (de) 1993-12-22 1996-02-01 Schering Ag Zusammensetzung für die Empfängnisverhütung
DE19549264A1 (de) * 1995-12-23 1997-06-26 Schering Ag Verfahren und Kit zur Kontrazeption
FR2754179B1 (fr) 1996-10-08 1998-12-24 Theramex Nouvelle composition hormononale et son utilisation
WO2001030355A1 (fr) * 1999-10-25 2001-05-03 Laboratoire Theramex Medicament contraceptif a base d'un progestatif et d'un estrogene et son mode de preparation
WO2001030356A1 (fr) * 1999-10-25 2001-05-03 Laboratoire Theramex Composition hormonale a base d'un progestatif et d'un estrogene et son utilisation
FR2814074B1 (fr) * 2000-09-15 2003-03-07 Theramex Nouvelles compositions estro-progestatives topiques a effet systemique
FR2823976A1 (fr) * 2001-04-25 2002-10-31 Theramex Nouvelle composition hormonale et son utilisation
UY29185A1 (es) * 2004-11-02 2006-05-31 Schering Ag Formas de dosificación oral sólidas que contienen una dosis baja de estradiol
AR065816A1 (es) * 2007-03-26 2009-07-01 Theramex Regimen anticonceptivo oral
US20080293683A1 (en) * 2007-05-24 2008-11-27 University Of Kansas Medical Center Hormone Replacement Therapy
TW200930343A (en) * 2007-09-21 2009-07-16 Organon Nv Drug delivery system
US10413504B2 (en) 2013-12-11 2019-09-17 Merck Sharp & Dohme Corp. Intravaginal ring drug delivery system
EP3079659B1 (en) 2013-12-11 2020-10-28 Merck Sharp & Dohme B.V. Drug delivery system for delivery of anti-virals
KR20240005348A (ko) 2022-07-05 2024-01-12 신규식 소멸특허 관리 및 특허거래 시스템

Family Cites Families (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3271392A (en) * 1965-09-14 1966-09-06 American Home Prod 17alpha-[3'-furyl]-estrogens
US4390531A (en) 1981-08-10 1983-06-28 Syntex Pharmaceuticals International Ltd. Method of contraception using peak progestogen dosage
US4921843A (en) 1988-10-20 1990-05-01 Pasquale Samuel A Contraception system and method
US4826831A (en) * 1983-08-05 1989-05-02 Pre Jay Holdings Limited Method of hormonal treatment for menopausal or post-menopausal disorders involving continuous administration of progestogens and estrogens
US4628051A (en) * 1983-09-26 1986-12-09 Ortho Pharmaceutical Corporation Triphasic oral contraceptive
JPS61243059A (ja) * 1985-04-19 1986-10-29 Konishi Kagaku Kogyo Kk 高純度４，４′−ジヒドロキシジフエニルスルホンの製造法
US5208225A (en) * 1986-02-27 1993-05-04 Warner-Lambert Company Compositions containing fixed combinations
ZA87332B (en) 1986-02-27 1987-08-26 Warner Lambert Co Compositions containing fixed combinations
DK174724B1 (da) 1986-07-15 2003-10-06 Wyeth Corp Anvendelse af et præparat omfattende et østrogen og et progestogen til fremstilling af en dosisform til tilvejebringelse af hormonerstatningsterapi og kontraception til kvinder i præmenopausen samt pakning til tilvejebringelse af præparatet
US5108995A (en) * 1987-09-24 1992-04-28 Jencap Research Ltd. Hormone preparation and method
US5256421A (en) * 1987-09-24 1993-10-26 Jencap Research Ltd. Hormone preparation and method
US5276022A (en) * 1987-09-24 1994-01-04 Jencap Research Ltd. Hormone preparation and method
CA1332227C (en) 1987-09-24 1994-10-04 Robert F. Casper Oral contraceptive formulation
NO301689B1 (no) * 1987-09-24 1997-12-01 Jencap Research Ltd Kontraseptivt preparat i form av en forpakning
HUT52382A (en) 1988-03-14 1990-07-28 Sandoz Ag Process for producing pharmaceutical compositions comprising as active ingredient unsubstituted progestin in 19-position and estrogen in the given case
IE71203B1 (en) 1990-12-13 1997-02-12 Akzo Nv Low estrogen oral contraceptives
IE62665B1 (en) 1990-12-17 1995-02-22 Akzo Nv Contraceptive regimen
FR2695826B1 (fr) * 1992-09-21 1995-01-06 Theramex Nouvelles compositions pharmaceutiques à base de dérivés de nomégestrol et leurs procédés d'obtention.
US6150343A (en) 1993-06-30 2000-11-21 University Of Pittsburgh Camptothecin analogs and methods of preparation thereof
US5554601A (en) * 1993-11-05 1996-09-10 University Of Florida Methods for neuroprotection
DE4344462C2 (de) * 1993-12-22 1996-02-01 Schering Ag Zusammensetzung für die Empfängnisverhütung
US5552394A (en) * 1994-07-22 1996-09-03 The Medical College Of Hampton Roads Low dose oral contraceptives with less breakthrough bleeding and sustained efficacy
US6613757B1 (en) 1994-09-22 2003-09-02 Board Of Regents, The University Of Texas System Combination of prostacyclin with an estrogen or progestin for the prevention and treatment of atherosclerotic vascular disease including preeclampsia and for the treatment of hypertension, and for hormone replacement therapy
SE9403389D0 (sv) 1994-10-06 1994-10-06 Astra Ab Pharmaceutical composition containing derivattves of sex hormones
FR2737411B1 (fr) * 1995-08-01 1997-10-17 Theramex Nouveaux medicaments hormonaux et leur utilisation pour la correction des carences estrogeniques
DE19540253C2 (de) 1995-10-28 1998-06-04 Jenapharm Gmbh Mehrphasenpräparat zur Kontrazeption auf der Basis natürlicher Estrogene
DE19549264A1 (de) 1995-12-23 1997-06-26 Schering Ag Verfahren und Kit zur Kontrazeption
WO1997041869A1 (en) 1996-05-08 1997-11-13 American Home Products Corporation Oral contraceptive
WO1997041868A1 (en) 1996-05-08 1997-11-13 American Home Products Corporation Oral contraceptive
AU2926897A (en) 1996-05-08 1997-11-26 American Home Products Corporation Oral contraceptive
WO1997041871A1 (en) 1996-05-08 1997-11-13 American Home Products Corporation Oral contraceptive
WO1997041872A1 (en) 1996-05-08 1997-11-13 American Home Products Corporation Oral contraceptive
US5888543A (en) * 1996-07-26 1999-03-30 American Home Products Corporation Oral contraceptives
WO1998004246A2 (en) 1996-07-26 1998-02-05 American Home Prod Triphasic contraceptive method and kit comprising a combination of a progestin and estrogen
AU3961697A (en) 1996-07-26 1998-02-20 American Home Products Corporation Oral contraceptive
ES2229378T3 (es) 1996-07-26 2005-04-16 Wyeth Anticonceptivo oral.
CA2261748A1 (en) 1996-07-26 1998-02-05 American Home Products Corporation Biphasic contraceptive method and kit comprising a combination of a progestin and estrogen
WO1998004267A1 (en) 1996-07-26 1998-02-05 American Home Products Corporation Progestin/estrogen oral contraceptive
WO2001030355A1 (fr) 1999-10-25 2001-05-03 Laboratoire Theramex Medicament contraceptif a base d'un progestatif et d'un estrogene et son mode de preparation
FR2754179B1 (fr) * 1996-10-08 1998-12-24 Theramex Nouvelle composition hormononale et son utilisation
DE19705229C2 (de) 1997-02-12 1999-04-15 Hesch Rolf Dieter Prof Dr Med Verwendung von drei Hormonkomponenten zur hormonalen Kontrazeption zur Behandlung und/oder Prophylaxe von Tumoren der Brustdrüsen
US5898032A (en) 1997-06-23 1999-04-27 Medical College Of Hampton Roads Ultra low dose oral contraceptives with less menstrual bleeding and sustained efficacy
PT1007052E (pt) 1997-08-27 2005-01-31 Ortho Mcneil Pharm Inc Combinacoes de progestinas de crescimento do endometrico e progestinas de atropia do endometrio com estrogenios, em contracepcao oral
DE19739916C2 (de) * 1997-09-11 2001-09-13 Hesch Rolf Dieter Verwendung einer Kombination aus einem Gestagen und einem Estrogen zur kontinuierlichen Ovulationshemmung und ggf. gleichzeitigen Behandlung und/oder Prophylaxe von Tumoren der Brustdrüsen
CA2301162A1 (en) 1997-09-12 1999-03-25 Michael Jay Gast Oral contraceptive preparation having a first phase comprising progestin/estrogen and a second phase comprising progestin
WO2001030356A1 (fr) 1999-10-25 2001-05-03 Laboratoire Theramex Composition hormonale a base d'un progestatif et d'un estrogene et son utilisation

Also Published As

Publication number Publication date
EP1334725B1 (fr) 2007-02-14
EP0956022A1 (fr) 1999-11-17
NO2017043I2 (no) 2019-01-25
KR100782638B1 (ko) 2007-12-06
YU18099A (sh) 2002-03-18
EP0956022B1 (fr) 2003-04-23
DE69737373D1 (de) 2007-03-29
US20070281912A1 (en) 2007-12-06
FR12C0005I1 (fr) 2012-02-24
OA11033A (fr) 2003-03-06
ES2198006T3 (es) 2004-01-16
PL332610A1 (en) 1999-09-27
EP1334725A3 (fr) 2004-01-21
PT956022E (pt) 2003-07-31
AU4627397A (en) 1998-05-05
FR2754179B1 (fr) 1998-12-24
HU227450B1 (en) 2011-06-28
EP1334725A2 (fr) 2003-08-13
NO2012002I2 (no) 2013-04-02
HK1210708A1 (en) 2016-05-06
CN104706641A (zh) 2015-06-17
NZ334876A (en) 2001-06-29
KR20060084864A (ko) 2006-07-25
NO2017043I1 (no) 2017-08-08
MA24370A1 (fr) 1998-07-01
FR2754179A1 (fr) 1998-04-10
ATE238057T1 (de) 2003-05-15
FR12C0005I2 (fr) 2016-06-24
LU91932I2 (fr) 2012-03-13
NO991593L (no) 1999-06-07
KR20000048981A (ko) 2000-07-25
US6831073B1 (en) 2004-12-14
ID21569A (id) 1999-06-24
TW491704B (en) 2002-06-21
DE69721314T2 (de) 2004-02-12
AU745571B2 (en) 2002-03-21
JP4883542B2 (ja) 2012-02-22
PT1334725E (pt) 2007-05-31
AP1171A (en) 2003-06-30
CZ298402B6 (cs) 2007-09-19
CN1239893A (zh) 1999-12-29
WO1998015279A1 (fr) 1998-04-16
RU2274450C2 (ru) 2006-04-20
IL129194A (en) 2003-06-24
US6906049B1 (en) 2005-06-14
HUP9904508A3 (en) 2001-01-29
SK285056B6 (sk) 2006-05-04
NO2012002I1 (no) 2012-01-24
TR199900764T2 (xx) 1999-07-21
JP2002509524A (ja) 2002-03-26
SK285455B6 (sk) 2007-01-04
ATE353652T1 (de) 2007-03-15
CL2011000017A1 (es) 2011-06-24
AP9901500A0 (en) 1999-06-30
ES2282539T3 (es) 2007-10-16
DK1334725T3 (da) 2007-06-11
LU91932I9 (cs) 2018-12-27
MY128482A (en) 2007-02-28
DK0956022T3 (da) 2003-08-04
HUP9904508A2 (hu) 2000-06-28
HUS1200002I1 (hu) 2016-08-29
US7749987B2 (en) 2010-07-06
DE122012000010I1 (de) 2012-04-19
BR9712274A (pt) 1999-08-31
CA2268358A1 (fr) 1998-04-16
DE69721314D1 (de) 2003-05-28
NO324357B1 (no) 2007-10-01
CZ9901120A3 (cs) 2000-11-15
TNSN97164A1 (fr) 1999-12-31
US20040220163A1 (en) 2004-11-04
DE69737373T2 (de) 2007-06-21
NO991593D0 (no) 1999-03-31
IL129194A0 (en) 2000-02-17
ZA979011B (en) 1998-06-03
SK43899A3 (en) 1999-12-10
CN101229173A (zh) 2008-07-30
CA2268358C (fr) 2010-04-20
AR009113A1 (es) 2000-03-08
PL192979B1 (pl) 2006-12-29
AR073972A2 (es) 2010-12-15

Similar Documents

Publication Publication Date Title
DZ3251A1 (fr) Nouvelle composition et son utilisation
PT1120392E (pt) Catalisador e composicao organometalica
BR9702553A (pt) Composição cosmética e utilização
FR2736263B1 (fr) Composition dermocosmetique depigmentante et son utilisation
NO985460D0 (no) Limsammensetning
DE69718508D1 (de) Antitraspirant zusammensetzung
PT941056E (pt) Composicoes de esfingomielinase e sua utilizacao
TR199700090A2 (tr) Yeni heteroaril-oksazolidinonlar.
NO982414D0 (no) Ny kombinasjon
FR2749507B1 (fr) Compositions cosmetiques detergentes et utilisation
ID18359A (id) Komposisi mikrokapsul
DZ2327A1 (fr) Nouvelle composition hormonale et son utilisation.
IS4898A (is) Sáraumbúðir
ID18344A (id) Komposisi kosmetik
EE9900524A (et) N-triasolüül-2-indoolkarboksamiidid ja nende kasutamine CCK-A agonistidena
DE59701070D1 (de) Schere
ID19589A (id) Komposisi
TR199501351A2 (tr) Uzatilmis sürede cisaprid saliverilmesi.
BR9707657A (pt) Benzotiofenos formulações contendo os mesmos e métodos
BR9708248A (pt) Benzotiofenos formulações contendo os mesmos e metódos
BR9709406B1 (pt) fluorenonas alquiloxiamino substituìdas e composição farmacêutica contendo as mesmas.
DE69718294D1 (de) Mittel zur verhinderung der hautalterung
BR9707835A (pt) Composiç
BR9709815A (pt) Composicão
NL1007839A1 (nl) Formulering en gebruik.